Market Overview:
The global medical surface disinfectant market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of hospital-acquired infections (HAIs), rising demand for advanced and effective disinfectants, and growing awareness about hygiene and sanitation. Based on type, the quaternary ammonium compounds segment is expected to lead the global medical surface disinfectant market during the forecast period. This can be attributed to their high efficacy against a wide range of microorganisms, including bacteria, viruses, and fungi. In terms of application, hospitals are expected to account for the largest share of the global medical surface disinfectant market during the forecast period.
Product Definition:
A medical surface disinfectant is a product that is used to clean and disinfect surfaces in a healthcare setting. Medical surface disinfectants are important because they help to prevent the spread of germs and bacteria.
Quaternary Ammonium Compounds:
Quaternary ammonium compounds are also known as quaternary ammonium hydroxide or quaternary amine hydroxide. It is a colorless, odorless, crystalline compound. It has a pungent odor similar to that of ammonia. Quaternary ammonium compounds are highly soluble in water (2g/100mL) and slightly soluble in alcohol (5% w/v).
Chlorhexidine Gluconate:
Chlorhexidine gluconate is a disinfectant and antiseptic used in medical surface disinfectants and antiseptics market. It has broad-spectrum bactericidal, fungicidal, and virucidal properties. Chlorhexidine gluconate is an odorless crystalline compound with a slightly sweet taste.
Application Insights:
The others segment held the largest share of the global medical surface disinfectant market in 2017. This is due to increasing demand for products from other application areas such as healthcare, hospitality, and food service industries. For instance, benzalkonium chloride is used for handwashing and cleaning surfaces in hospitals and clinics owing to its antiseptic properties. However, clinical laboratories account for a significant share of revenue as well because these facilities require high-quality disinfectants that do not affect test results negatively.
Hospitals are expected to be one of the fastest-growing segments over the forecast period owing to rising investments in advanced healthcare infrastructure across various countries worldwide coupled with an increase in spending on healthcare services per capita among their population. Furthermore, stringent government regulations regarding hospital hygiene management are anticipated to further drive growth over next few years globally without affecting product quality or performance too much during use at higher concentrations than required levels (i.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing cases of hospital-acquired infections, rising government initiatives for promoting patient safety, and high adoption of advanced surface disinfectants by hospitals across this region.
Asia Pacific is anticipated to witness a lucrative growth rate over the forecast period owing to factors such as improving healthcare infrastructure and growing awareness about hygiene among patients & visitors at hospitals in this region. In addition, increasing number of product launches coupled with stringent regulations by regulatory bodies regarding use of proper equipment for medical purposes are some other factors driving regional growth during the estimated time span.
Latin America also presents significant opportunities due to presence of developing countries such as Brazil.
Growth Factors:
- Increasing incidence of hospital-acquired infections (HAIs) is expected to drive the demand for medical surface disinfectants over the forecast period.
- Rising awareness about the benefits of using medical surface disinfectants is anticipated to boost market growth.
- Growing number of surgical procedures and increasing demand for sterile environments are expected to fuel market growth over the next few years.
- Technological advancements in medical surface disinfectants are projected to create new opportunities for market players in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Surface Disinfectant Market Research Report
By Type
Quaternary Ammonium Compounds, Chlorhexidine Gluconate, Phenolic Compounds, Alcohols, Aldehydes, Other
By Application
Hospitals, Clinical Laboratories, Pharmaceutical Companies, Others
By Companies
3M Company (US), Johnson & Johnson (US), Cantel Medical Corporation (US), Procter & Gamble (US), Reckitt Benckiser Group plc. (UK), The Clorox Company (US), Sealed Air Corporation (US), Ecolab (US), Steris Corporation (US), Carroll Company (US), Danaher Corporation (US), Pal International Ltd. (UK), Whiteley Corporation (AU)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Medical Surface Disinfectant Market Report Segments:
The global Medical Surface Disinfectant market is segmented on the basis of:
Types
Quaternary Ammonium Compounds, Chlorhexidine Gluconate, Phenolic Compounds, Alcohols, Aldehydes, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinical Laboratories, Pharmaceutical Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M Company (US)
- Johnson & Johnson (US)
- Cantel Medical Corporation (US)
- Procter & Gamble (US)
- Reckitt Benckiser Group plc. (UK)
- The Clorox Company (US)
- Sealed Air Corporation (US)
- Ecolab (US)
- Steris Corporation (US)
- Carroll Company (US)
- Danaher Corporation (US)
- Pal International Ltd. (UK)
- Whiteley Corporation (AU)
Highlights of The Medical Surface Disinfectant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Quaternary Ammonium Compounds
- Chlorhexidine Gluconate
- Phenolic Compounds
- Alcohols
- Aldehydes
- Other
- By Application:
- Hospitals
- Clinical Laboratories
- Pharmaceutical Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Surface Disinfectant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical surface disinfectant is a type of disinfectant that is used on medical equipment and surfaces. It kills bacteria and other microorganisms that may be present on the equipment or surface.
Some of the major companies in the medical surface disinfectant market are 3M Company (US), Johnson & Johnson (US), Cantel Medical Corporation (US), Procter & Gamble (US), Reckitt Benckiser Group plc. (UK), The Clorox Company (US), Sealed Air Corporation (US), Ecolab (US), Steris Corporation (US), Carroll Company (US), Danaher Corporation (US), Pal International Ltd. (UK), Whiteley Corporation (AU).
The medical surface disinfectant market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Surface Disinfectant Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Surface Disinfectant Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Surface Disinfectant Market - Supply Chain
4.5. Global Medical Surface Disinfectant Market Forecast
4.5.1. Medical Surface Disinfectant Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Surface Disinfectant Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Surface Disinfectant Market Absolute $ Opportunity
5. Global Medical Surface Disinfectant Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Surface Disinfectant Market Size and Volume Forecast by Type
5.3.1. Quaternary Ammonium Compounds
5.3.2. Chlorhexidine Gluconate
5.3.3. Phenolic Compounds
5.3.4. Alcohols
5.3.5. Aldehydes
5.3.6. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Surface Disinfectant Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Surface Disinfectant Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinical Laboratories
6.3.3. Pharmaceutical Companies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Surface Disinfectant Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Surface Disinfectant Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Surface Disinfectant Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Surface Disinfectant Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Surface Disinfectant Demand Share Forecast, 2019-2026
9. North America Medical Surface Disinfectant Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Surface Disinfectant Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Surface Disinfectant Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinical Laboratories
9.4.3. Pharmaceutical Companies
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Surface Disinfectant Market Size and Volume Forecast by Type
9.7.1. Quaternary Ammonium Compounds
9.7.2. Chlorhexidine Gluconate
9.7.3. Phenolic Compounds
9.7.4. Alcohols
9.7.5. Aldehydes
9.7.6. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Surface Disinfectant Demand Share Forecast, 2019-2026
10. Latin America Medical Surface Disinfectant Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Surface Disinfectant Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Surface Disinfectant Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinical Laboratories
10.4.3. Pharmaceutical Companies
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Surface Disinfectant Market Size and Volume Forecast by Type
10.7.1. Quaternary Ammonium Compounds
10.7.2. Chlorhexidine Gluconate
10.7.3. Phenolic Compounds
10.7.4. Alcohols
10.7.5. Aldehydes
10.7.6. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Surface Disinfectant Demand Share Forecast, 2019-2026
11. Europe Medical Surface Disinfectant Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Surface Disinfectant Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Surface Disinfectant Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinical Laboratories
11.4.3. Pharmaceutical Companies
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Surface Disinfectant Market Size and Volume Forecast by Type
11.7.1. Quaternary Ammonium Compounds
11.7.2. Chlorhexidine Gluconate
11.7.3. Phenolic Compounds
11.7.4. Alcohols
11.7.5. Aldehydes
11.7.6. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Surface Disinfectant Demand Share, 2019-2026
12. Asia Pacific Medical Surface Disinfectant Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Surface Disinfectant Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Surface Disinfectant Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinical Laboratories
12.4.3. Pharmaceutical Companies
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Surface Disinfectant Market Size and Volume Forecast by Type
12.7.1. Quaternary Ammonium Compounds
12.7.2. Chlorhexidine Gluconate
12.7.3. Phenolic Compounds
12.7.4. Alcohols
12.7.5. Aldehydes
12.7.6. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Surface Disinfectant Demand Share, 2019-2026
13. Middle East & Africa Medical Surface Disinfectant Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Surface Disinfectant Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Surface Disinfectant Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinical Laboratories
13.4.3. Pharmaceutical Companies
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Surface Disinfectant Market Size and Volume Forecast by Type
13.7.1. Quaternary Ammonium Compounds
13.7.2. Chlorhexidine Gluconate
13.7.3. Phenolic Compounds
13.7.4. Alcohols
13.7.5. Aldehydes
13.7.6. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Surface Disinfectant Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Surface Disinfectant Market: Market Share Analysis
14.2. Medical Surface Disinfectant Distributors and Customers
14.3. Medical Surface Disinfectant Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M Company (US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson (US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cantel Medical Corporation (US)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Procter & Gamble (US)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Reckitt Benckiser Group plc. (UK)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. The Clorox Company (US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sealed Air Corporation (US)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ecolab (US)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Steris Corporation (US)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Carroll Company (US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Danaher Corporation (US)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Pal International Ltd. (UK)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Whiteley Corporation (AU)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
